Cargando…
Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442945/ https://www.ncbi.nlm.nih.gov/pubmed/37614315 http://dx.doi.org/10.3389/fphar.2023.1252315 |
_version_ | 1785093713017438208 |
---|---|
author | Bhatia, Divya Srivastava, Swayam Prakash |
author_facet | Bhatia, Divya Srivastava, Swayam Prakash |
author_sort | Bhatia, Divya |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10442945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104429452023-08-23 Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms Bhatia, Divya Srivastava, Swayam Prakash Front Pharmacol Pharmacology Frontiers Media S.A. 2023-08-08 /pmc/articles/PMC10442945/ /pubmed/37614315 http://dx.doi.org/10.3389/fphar.2023.1252315 Text en Copyright © 2023 Bhatia and Srivastava. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Bhatia, Divya Srivastava, Swayam Prakash Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms |
title | Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms |
title_full | Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms |
title_fullStr | Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms |
title_full_unstemmed | Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms |
title_short | Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms |
title_sort | editorial: diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442945/ https://www.ncbi.nlm.nih.gov/pubmed/37614315 http://dx.doi.org/10.3389/fphar.2023.1252315 |
work_keys_str_mv | AT bhatiadivya editorialdiabetickidneydiseaseroutestodrugdevelopmentpharmacologyandunderlyingmolecularmechanisms AT srivastavaswayamprakash editorialdiabetickidneydiseaseroutestodrugdevelopmentpharmacologyandunderlyingmolecularmechanisms |